Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage.

[1]  J. Hoffmann,et al.  Detection of soluble adhesion molecules in pleural effusions. , 1996, Chest.

[2]  J. Woska,et al.  Characterization of molecular interactions between intercellular adhesion molecule-1 and leukocyte function- associated antigen-1. , 1996, Journal of immunology.

[3]  T. Tötterman,et al.  Elevated serum levels of soluble ICAM‐1 in non‐Hodgkin’s lymphomas correlate with tumour burden, disease activity and other prognostic markers , 1996, British journal of haematology.

[4]  J. Krutmann,et al.  Analysis of the production of soluble ICAM-1 molecules by human cells. , 1996, Experimental hematology.

[5]  D. Adu,et al.  Circulating soluble adhesion molecules in inflammatory bowel disease , 1995, European journal of gastroenterology & hepatology.

[6]  Michael Loran Dustin,et al.  Characterization of intercellular adhesion molecule-1 ectodomain (sICAM-1) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1. , 1995, Journal of immunology.

[7]  T. Tötterman,et al.  Soluble ICAM-1 in Hodgkin's disease: a promising independent predictive marker for survival. , 1995, Leukemia & lymphoma.

[8]  S. Dubinett,et al.  Human Non-Small Cell Lung Cancer Cells Express a Type 2 Cytokine Pattern 1 , 2006 .

[9]  Enzo Galligioni,et al.  Expression and release of intercellular adhesion molecule‐1 in renal‐cancer patients , 1995, International journal of cancer.

[10]  W. Brück,et al.  Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells , 1995, Journal of Neuroimmunology.

[11]  M. Mishaeli,et al.  The significance of soluble interleukin-2, soluble interleukin-2 receptors, soluble ICAM-1 and beta 2-microglobulin in breast cancer patients. , 1995, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[12]  T. Carlos,et al.  Leukocyte-endothelial adhesion molecules. , 1994, Blood.

[13]  S. Martin,et al.  Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus , 1994, The Lancet.

[14]  J. Schwartz,et al.  Cigarette smoking and peripheral blood leukocyte differentials. , 1994, Annals of epidemiology.

[15]  D. Adams,et al.  Leucocyte-endothelial interactions and regulation of leucocyte migration , 1994, The Lancet.

[16]  T. Horie,et al.  Elevation of serum soluble intercellular adhesion molecule‐1 (sICAM‐1) and sE‐selectin levels in bronchial asthma , 1994, Clinical and experimental immunology.

[17]  T. Tötterman,et al.  Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers. , 1994, Blood.

[18]  J. Becker,et al.  Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction. , 1993, Journal of Immunology.

[19]  A. Gearing,et al.  Circulating adhesion molecules in disease. , 1993, Immunology today.

[20]  G. Ramadori,et al.  Intercellular adhesion molecule‐1 concentration in sera of patients with acute and chronic liver disease: Relationship to disease activity and cirrhosis , 1993, Hepatology.

[21]  F. Herrmann,et al.  Serum levels of circulating ICAM-1 are increased in Hodgkin's disease. , 1993, Leukemia.

[22]  M. Maio,et al.  Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. , 1993, Cancer research.

[23]  P. Selby,et al.  Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. , 1993, British Journal of Cancer.

[24]  D. Staunton,et al.  Functional studies of truncated soluble intercellular adhesion molecule 1 expressed in Escherichia coli , 1993, Antimicrobial Agents and Chemotherapy.

[25]  N. Yanagisawa,et al.  Increases levels of circulating intercellular adhesion molecule‐1 in multiple sclerosis and human T‐lymphotropic virus type I‐associated myelopathy , 1993, Annals of neurology.

[26]  F. Takei,et al.  Inhibition of cell adhesion by microspheres coated with recombinant soluble intercellular adhesion molecule-1. , 1993, Journal of immunology.

[27]  E. Thompson,et al.  Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-α and blood-brain barrier damage , 1993, Journal of Neuroimmunology.

[28]  L. Liotta,et al.  Molecular aspects of tumor cell invasion and metastasis , 1993, Cancer.

[29]  K. Havemann,et al.  Differential expression of the intercellular adhesion molecule-1 (ICAM-1) in lung cancer cell lines of various histological types. , 1993, European journal of cancer.

[30]  K. Imai,et al.  Soluble ICAM-1 levels in serum during acute infectious mononucleosis. , 1993, Scandinavian journal of infectious diseases.

[31]  C. Mackay,et al.  Cell adhesion in the immune system. , 1993, Immunology today.

[32]  I. Stamenkovic,et al.  Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumor‐infiltrating lymphocytes , 2010, Cancer.

[33]  S. J. Cashman,et al.  Soluble Forms of Vascular Adhesion Molecules, E‐Selectin, ICAM‐1, and VCAM‐1: Pathological Significance , 1992, Annals of the New York Academy of Sciences.

[34]  R. Giavazzi,et al.  Soluble intercellular adhesion molecule 1 is released by human melanoma cells and is associated with tumor growth in nude mice. , 1992, Cancer research.

[35]  J. Becker,et al.  Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. , 1991, Journal of immunology.

[36]  R. Rothlein,et al.  A form of circulating ICAM-1 in human serum. , 1991, Journal of immunology.

[37]  R. Rothlein,et al.  Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. , 1991, Cancer research.

[38]  M. Makgoba,et al.  Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders , 1991, The Lancet.

[39]  Y. Hinoda,et al.  Detection of circulating intercellular adhesion molecule‐1 antigen in malignant diseases , 1991, Clinical and experimental immunology.

[40]  M. Diamond,et al.  ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18) , 1990, The Journal of cell biology.

[41]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[42]  C. Forbes,et al.  White Blood Cell Count and Haematocrit as Predictors of Coronary Recurrence after Myocardial Infarction , 1985, Thrombosis and Haemostasis.

[43]  T. Beritić,et al.  [Allergic alveolitis]. , 1969, Arhiv za higijenu rada i toksikologiju.

[44]  J. W. Sever.  THE WHITE BLOOD CELL COUNT , 1933 .